STOCK TITAN

Insider files Form 144: IBRX (NASDAQ: IBRX) plans sale of 159,478 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

The issuer reports a proposed resale of 159,478 common shares related to an exercise of stock options to be settled for cash on 07/01/2026. The filing also records recent 10b5-1 sales of 95,722 shares and 1,000 shares on 06/29/2026 and 06/30/2026, respectively, with proceeds shown.

Positive

  • None.

Negative

  • None.
Proposed resale 159,478 shares exercise of stock options, <date>07/01/2026</date>
10b5-1 sale 95,722 shares sale on <date>06/29/2026</date>, proceeds $862,212.63
10b5-1 sale 1,000 shares sale on <date>06/30/2026</date>, proceeds $9,000.00
Form 144 regulatory
"Notice of proposed sale of restricted or control securities"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
10b5-1 regulatory
"Listed as "10b5-1 Sales" for Christobel Selecky"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Exercise of Stock Options financial
"Securities To Be Sold — Exercise of Stock Options — Cash settlement"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does IBRX's Form 144 report?

It notifies a proposed sale of 159,478 shares. The filing ties that amount to an exercise of stock options with cash settlement on 07/01/2026. It also lists recent 10b5-1 sales of 95,722 and 1,000 shares on June 29 and 30, 2026.

Who executed recent 10b5-1 sales noted in the filing?

Christobel Selecky is named as the 10b5-1 seller for the two recent transactions. The filing shows sales of 95,722 shares for $862,212.63 and 1,000 shares for $9,000 on the dates provided.

Are the 159,478 shares being sold already sold or proposed?

They are proposed for resale. The Form 144 indicates the shares relate to an exercise of stock options and are listed for sale with a cash settlement method on 07/01/2026, rather than recorded as completed sales in the filing.

How much cash did the recent 10b5-1 sales generate?

Combined proceeds shown total $871,212.63. The filing lists proceeds of $862,212.63 from the 95,722-share sale and $9,000.00 from the 1,000-share sale on the stated dates in June 2026.